Product Information
LEVETIRACETAM 250 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0599 per EA under NDC 64980060412. Its NADAC has been published 99 times since Aug 7, 2024.
Strength
250 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
64980060412
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LEVETIRACETAMApproval Type
Generic (ANDA)
FDA Application
ANDA090767On Market Since
6/10/2024
Pharmacological Classes
Price Statistics
The NADAC for LEVETIRACETAM 250 MG TABLET has been published 99 times since Aug 7, 2024, and over the history we have for it it has risen 21.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0599 per EA |
|---|---|
| All-time high | $0.0645 (Sep 11, 2024) |
| All-time low | $0.0454 (Nov 20, 2024) |
| 52-week high | $0.0638 |
| 52-week low | $0.0562 |
| Median price | $0.0600 |
| Average price | $0.0588 |
| Largest weekly change | +30.7% (Aug 21, 2024) |
| Weeks tracked | 99 |
| Tracking since | Aug 7, 2024 |
Generic Alternatives
The matcher finds 17 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 18% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LEVETIRACETAM 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVETIRACETAM 250 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0599 per EA (NDC 64980060412), effective Jun 24, 2026.
How has the price of LEVETIRACETAM 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for LEVETIRACETAM 250 MG TABLET has risen 21.3%. It has been tracked across 99 weekly CMS publications since Aug 7, 2024.
What are the highest and lowest recorded NADAC prices for LEVETIRACETAM 250 MG TABLET?
Since Aug 7, 2024, the NADAC for LEVETIRACETAM 250 MG TABLET has ranged from a low of $0.0454 (Nov 20, 2024) to a high of $0.0645 (Sep 11, 2024), with a median of $0.0600 per EA.
Are there cheaper alternatives to LEVETIRACETAM 250 MG TABLET?
Yes. 17 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LEVETIRACETAM 250 MG TABLET, is $0.0494 per EA — about 18% below LEVETIRACETAM 250 MG TABLET.
Who manufactures LEVETIRACETAM 250 MG TABLET?
LEVETIRACETAM 250 MG TABLET (NDC 64980060412) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification